RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vakaramoko Diaby to Abnormalities, Drug-Induced

Back to Details
This is a "connection" page, showing publications Vakaramoko Diaby has written about Abnormalities, Drug-Induced.
Vakaramoko Diaby
Connection Strength
0.227
Abnormalities, Drug-Induced
  1. Winterstein AG, Ewig CLY, Wang Y, Smolinski NE, Toyserkani GA, LaCivita C, Lackey L, Eggers S, Zhou EH, Diaby V, Sarayani A, Thai T, Maro JC, Rasmussen SA. Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. Drug Saf. 2025 Feb; 48(2):107-117.
    View in: PubMed
    Score: 0.227
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support